Merck & Co., Inc.
MRK
$148.35
-$1.19-0.80%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 66.57B | 65.77B | 65.01B | 64.24B | 63.62B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.57B | 65.77B | 65.01B | 64.24B | 63.62B |
| Cost of Revenue | 16.04B | 15.31B | 14.82B | 14.23B | 14.37B |
| Gross Profit | 50.53B | 50.46B | 50.20B | 50.01B | 49.25B |
| SG&A Expenses | 10.56B | 10.28B | 10.11B | 10.07B | 10.13B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.90B | 41.13B | 40.44B | 36.95B | 39.01B |
| Operating Income | 18.67B | 24.63B | 24.57B | 27.29B | 24.61B |
| Income Before Tax | 5.95B | 11.63B | 21.07B | 21.82B | 19.16B |
| Income Tax Expenses | 2.78B | 2.70B | 2.81B | 2.77B | 2.74B |
| Earnings from Continuing Operations | 3.17K | 8.93K | 18.26K | 19.04K | 16.42K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.00M | 1.00M | -8.00M | -10.00M | -12.00M |
| Net Income | 3.17B | 8.94B | 18.25B | 19.03B | 16.41B |
| EBIT | 18.67B | 24.63B | 24.57B | 27.29B | 24.61B |
| EBITDA | 24.06B | 29.62B | 29.21B | 31.62B | 28.99B |
| EPS Basic | 1.25 | 3.56 | 7.29 | 7.57 | 6.50 |
| Normalized Basic EPS | 4.30 | 5.84 | 5.85 | 6.52 | 5.91 |
| EPS Diluted | 1.25 | 3.55 | 7.28 | 7.56 | 6.49 |
| Normalized Diluted EPS | 4.29 | 5.83 | 5.84 | 6.51 | 5.90 |
| Average Basic Shares Outstanding | 9.93B | 9.97B | 10.02B | 10.07B | 10.10B |
| Average Diluted Shares Outstanding | 9.93B | 9.97B | 10.03B | 10.08B | 10.12B |
| Dividend Per Share | 3.32 | 3.28 | 3.24 | 3.20 | 3.16 |
| Payout Ratio | 261.52% | 92.12% | 44.79% | 42.60% | 48.95% |